Brief: Invivo Therapeutics Holdings Reports Q3 Loss Per Share Of $0.42

InVivo Therapeutics Holdings

08/11/2018 22:12

Nov 8 (Reuters) - InVivo Therapeutics Holdings Corp
 NVIV.O :
    * INVIVO THERAPEUTICS REPORTS 2018 THIRD QUARTER FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATE
    * Q3 LOSS PER SHARE $0.42
    * ENDED QUARTER WITH $19.7 MILLION OF CASH AND CASH
EQUIVALENTS
    * ANNOUNCES WESTERN INSTITUTIONAL REVIEW BOARD APPROVAL FOR
SELECT
INSPIRE 2.0 STUDY SITES -
    * ANTICIPATE INITIATION OF PATIENT ENROLLMENT IN INSPIRE 2.0
STUDY
IN Q4

Source text for Eikon:  ID:nBw28kQB5a 
Further company coverage:  NVIV.O 

 (Reuters.Briefs@thomsonreuters.com)